Literature DB >> 15995902

Affective processes in the onset and persistence of psychosis.

Lydia Krabbendam1, Jim van Os.   

Abstract

OBJECTIVES: Cognitive models suggest that beliefs and appraisal processes are crucially important in the onset and persistence of psychosis. This study investigated whether (i) neuroticism increases the risk for development of psychotic symptoms, and (ii) a delusional interpretation and/or a depressed response to hallucinatory experiences predicts the onset of psychotic disorder.
METHOD: A general population sample with no lifetime evidence of any psychotic disorder was interviewed with the Composite International Diagnostic Interview Schedule (CIDI) at baseline and 1 and 3 years later. At year 3, individuals with CIDI evidence of psychotic symptoms were interviewed by clinicians to identify onset of psychotic disorder.
RESULTS: Baseline level of neuroticism increases the risk for incident psychotic symptoms. Given the presence of hallucinatory experiences at baseline, the increase in risk of having the psychosis outcome was much higher in the group with delusional ideation or depressed mood at year 1 than in those without delusional ideation or depressed mood.
CONCLUSION: A cognitive style characterised by a tendency to worry increases the risk for newly developed psychotic symptoms. Individuals who report hallucinatory experiences and react to these with a delusional interpretation and/or negative emotional states have an increased risk for developing clinical psychosis.

Entities:  

Mesh:

Year:  2005        PMID: 15995902     DOI: 10.1007/s00406-005-0586-6

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  37 in total

1.  Measurement of delusional ideation in the normal population: introducing the PDI (Peters et al. Delusions Inventory).

Authors:  E R Peters; S A Joseph; P A Garety
Journal:  Schizophr Bull       Date:  1999       Impact factor: 9.306

2.  A cognitive model of the positive symptoms of psychosis.

Authors:  P A Garety; E Kuipers; D Fowler; D Freeman; P E Bebbington
Journal:  Psychol Med       Date:  2001-02       Impact factor: 7.723

3.  Causal attributions in paranoia and depression: internal, personal, and situational attributions for negative events.

Authors:  P Kinderman; R P Bentall
Journal:  J Abnorm Psychol       Date:  1997-05

4.  Screening for psychosis in the general population with a self-report interview.

Authors:  W W Eaton; A Romanoski; J C Anthony; G Nestadt
Journal:  J Nerv Ment Dis       Date:  1991-11       Impact factor: 2.254

5.  The factor structure of "schizotypal' traits: a large replication study.

Authors:  G Claridge; C McCreery; O Mason; R Bentall; G Boyle; P Slade; D Popplewell
Journal:  Br J Clin Psychol       Date:  1996-02

6.  Occurrence of hallucinatory experiences in a community sample and ethnic variations.

Authors:  Louise C Johns; James Y Nazroo; Paul Bebbington; Elizabeth Kuipers
Journal:  Br J Psychiatry       Date:  2002-02       Impact factor: 9.319

7.  Intrusive thoughts and auditory hallucinations: a comparative study of intrusions in psychosis.

Authors:  A P Morrison; C A Baker
Journal:  Behav Res Ther       Date:  2000-11

8.  The relationships between neuroticism and depressive symptoms.

Authors:  D M Fergusson; L J Horwood; J M Lawton
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1989-11       Impact factor: 4.328

9.  The omnipotence of voices. A cognitive approach to auditory hallucinations.

Authors:  P Chadwick; M Birchwood
Journal:  Br J Psychiatry       Date:  1994-02       Impact factor: 9.319

10.  Exploring 'theory of mind' in people with schizophrenia.

Authors:  C D Frith; R Corcoran
Journal:  Psychol Med       Date:  1996-05       Impact factor: 7.723

View more
  8 in total

1.  Reappraisal of the interplay between psychosis and depression symptoms in the pathogenesis of psychotic syndromes: results from a twenty-year prospective community study.

Authors:  Wulf Rössler; Jules Angst; Alex Gamma; Helene Haker; Niklaus Stulz; Kathleen R Merikangas; Vladeta Ajdacic-Gross
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-07-13       Impact factor: 5.270

Review 2.  Are the effects of duration of untreated psychosis socially mediated?

Authors:  Ross M G Norman
Journal:  Can J Psychiatry       Date:  2014-10       Impact factor: 4.356

3.  The psychosis continuum in the general population: findings from the São Paulo Epidemiologic Catchment Area Study.

Authors:  Alexandre Andrade Loch; Yuan-Pang Wang; Wulf Rössler; Luis Fernando Tófoli; Camila Magalhães Silveira; Laura Helena Andrade
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-03-16       Impact factor: 5.270

Review 4.  Affective traits in schizophrenia and schizotypy.

Authors:  William P Horan; Jack J Blanchard; Lee Anna Clark; Michael F Green
Journal:  Schizophr Bull       Date:  2008-07-29       Impact factor: 9.306

5.  The structure of the extended psychosis phenotype in early adolescence--a cross-sample replication.

Authors:  Johanna T W Wigman; Wilma A M Vollebergh; Quinten A W Raaijmakers; Jurjen Iedema; Saskia van Dorsselaer; Johan Ormel; Frank C Verhulst; Jim van Os
Journal:  Schizophr Bull       Date:  2009-12-31       Impact factor: 9.306

6.  Failure of neural responses to safety cues in schizophrenia.

Authors:  Daphne J Holt; Garth Coombs; Mohamed A Zeidan; Donald C Goff; Mohammed R Milad
Journal:  Arch Gen Psychiatry       Date:  2012-09

7.  Psychosis risk as a function of age at onset: a comparison between early- and late-onset psychosis in a general population sample.

Authors:  Sebastian Köhler; Jim van Os; Ron de Graaf; Wilma Vollebergh; Frans Verhey; Lydia Krabbendam
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-03-12       Impact factor: 4.328

8.  Appraisals of psychotic experiences: an experimental investigation of symptomatic, remitted and non-need-for-care individuals.

Authors:  R Underwood; V Kumari; E Peters
Journal:  Psychol Med       Date:  2016-01-25       Impact factor: 7.723

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.